Teladoc Health (NYSE: TDOC), a global leader in comprehensive virtual care, is providing complimentary 24/7 general medical telehealth consultations to Texas residents, first responders, and others directly impacted by Hurricane…
Baxter International Inc. (NYSE), a global medtech leader, has published its 2023 Corporate Responsibility Report, highlighting its ongoing commitment to impactful global healthcare and transparent reporting on environmental, social, and…
EO Care, a leader in clinically guided cannabinoid-based healthcare treatment, announced today that Milliman, a premier global consulting and actuarial firm, has completed its review of EO Care’s proprietary cost…
Zura Bio Limited (NASDAQ: ZURA), a clinical-stage immunology company specializing in novel dual-pathway antibodies for autoimmune and inflammatory diseases, has announced the commencement of an exchange offer (the “Offer”) and…
Galderma has announced the U.S. exclusive launch of two new innovations in its Cetaphil product line: the Vitamin C Serum and the Ceramide Serum. According to clinical studies, the Cetaphil…
Chemed Corporation (NYSE: CHE) announced today that it will release its financial results for the second quarter ended June 30, 2024, on Wednesday, July 24, 2024, after the close of…
MySpaLive, a leader in the aesthetics industry, is thrilled to announce its expansion into five new states: Arizona, Arkansas, Oklahoma, Washington, and Georgia. This strategic move aims to provide Registered…
Please replace the release issued April 11, 2024 with the following corrected version due to multiple revisions. “Insurance coverage equals access for most women in the U.S.” The updated release…
ResearchAndMarkets.com has recently introduced the “Diagnostic Imaging Collaboration and Licensing Deals 2016-2024” report, offering an extensive exploration into the diagnostic imaging agreements undertaken by prominent biopharma companies globally. This updated…
Freeflow Ventures, a venture capital firm specializing in science-driven solutions to human and planetary health challenges, has raised $50M in new funds, comprising a $35M Fund Two and a $15M…
The “Biosimilars Training Course” conference is now available through ResearchAndMarkets.com, providing a crucial opportunity to anticipate and capitalize on the imminent growth within the biosimilars market. As numerous prominent biologics…
Merck (NYSE: MRK), also known as MSD outside of the United States and Canada, announced today that the U.S. Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization…